Intellia Therapeutics, Inc. (NTLA)
9.06
-0.08
(-0.88%)
USD |
NASDAQ |
Dec 30, 16:00
9.07
+0.01
(+0.11%)
After-Hours: 20:00
Intellia Therapeutics Market Cap: 1.049B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.784B |
| Regeneron Pharmaceuticals, Inc. | 81.34B |
| Beam Therapeutics, Inc. | 2.823B |
| Vertex Pharmaceuticals, Inc. | 115.12B |
| Pacific Biosciences of California, Inc. | 522.30M |
Market Cap Related Metrics
| PS Ratio | 16.51 |
| Price to Book Value | 1.402 |
| Price | 9.06 |
| Earnings Yield | -47.08% |